肝癌介入化疗患者医院感染的临床特征与预防

Clinical characteristics and prevention of nosocomial infections in patients with liver cancer after interventional chemotherapy

  • 摘要: 目的 探讨肝癌介入化疗患者发生医院感染的临床特征及预防对策,为临床治疗提供参考依据。方法 选择2014年8月-2015年7月于医院行介入化疗的肝癌患者208例,制定调查表,对发生医院感染患者的临床资料进行调查分析,数据采用SPSS 19.0软件进行统计分析。结果 208例肝癌介入化疗患者中发生医院感染17例,感染率8.17%;感染部位以肺部、腹部感染为主,分别占35.29%、23.53%;17例医院感染患者中共检出31株病原菌,以大肠埃希菌为主,共10株占32.25%。结论 临床上针对肝癌介入化疗的医院感染易感患者,医师与护理人员应采取积极的预防对策,以减少医院感染的发生率。

     

    Abstract: OBJECTIVE To investigate the clinical characteristics and preventive measures of nosocomial infections in patients with liver cancer after interventional chemotherapy, so as to provide reference for clinical treatment. METHODS A total of 208 cases of patients with liver cancer after interventional chemotherapy in hospital from Aug. 2014 to Jul. 2015 were selected. The clinical data of patients with nosocomial infections were investigated and analyzed by using questionnaire. The statistical analysis was conducted by SPSS19.0 software. RESULTS A total of 208 cases of patients with liver cancer after interventional chemotherapy, nosocomial infections occurred in 17 cases, with infection rate of 8.17%. The infection was mainly caused by pulmonary and abdominal infections, accounting for 35.29% and 23.53%. A total of 31 strains of pathogenic bacteria were detected from the 17 cases of nosocomial infection patients, mainly Escherichia coli, 10 strains, accounting for 32.25%. CONCLUSION In view of the nosocomial infections in patients with liver cancer treated by intervention chemotherapy, doctors and nurses should take active preventive measures to reduce the incidence of nosocomial infection.

     

/

返回文章
返回